HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A recalcitrant acrodermatitis continua of Hallopeau successfully treated with etanercept.

Abstract
Acrodermatitis continua of Hallopeau (ACH) is considered as a localized form of pustularpsoriasis that is usually refractory to the treatment. The condition is characterized by sterile pustules, onychodystrophy, anonychia, and osteolysis of distal phalanges. The authors report a case of recalcitrant ACH who previously failed to topical corticosteroid, methotrexate, acitretin, and phototherapy and rapidly responded to etanercept in combination with acitretin. The primary varicella infection occurred during the therapy. The patient was able to discontinue etanercept within four months after starting the treatment. The lesion was then under-controlled by acitretin and topical clobetasol ointment with an 8-month clinical remission.
AuthorsNarumol Silpa-archa, Chanisada Wongpraparut
JournalJournal of the Medical Association of Thailand = Chotmaihet thangphaet (J Med Assoc Thai) Vol. 94 Issue 9 Pg. 1154-7 (Sep 2011) ISSN: 0125-2208 [Print] Thailand
PMID21970208 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Immunoglobulin G
  • Keratolytic Agents
  • Receptors, Tumor Necrosis Factor
  • Acitretin
  • Etanercept
Topics
  • Acitretin (administration & dosage)
  • Acrodermatitis (diagnosis, drug therapy)
  • Adult
  • Anti-Inflammatory Agents, Non-Steroidal (administration & dosage)
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Etanercept
  • Female
  • Humans
  • Immunoglobulin G (administration & dosage)
  • Keratolytic Agents (administration & dosage)
  • Receptors, Tumor Necrosis Factor (administration & dosage)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: